Medovex Corp. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs on animals to assess a product’s safety profile.
The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.
“We are pleased that The DenerveX Device has now proven itself in a total of 16 animal tests, three cadaver labs with at least four cadavers in each lab and numerous bench tests over the course of its development.” Read the full article
Medovex Corp. engages in development of medical devices. Its activities include obtaining, development, and commercialization of various intellectual property rights such as patents, patent applications, and knowhow in the field of medical technology. Its pipeline, DenerveX device, provides relief from pain associated with the facet joint syndrome. The company was founded by Steven Gorlin on July 30, 2013 and is headquartered in Altanta, GA. [Source: MarketWatch]
Company Website: http://medovex.com